MONTREAL, QUEBEC--(Marketwire - October 15, 2007) - Osta Biotechnologies (TSX VENTURE: OBI), a Montreal-based biotechnology company involved in the discovery and development of novel diagnostics and therapeutics and the Jewish General Hospital’s Segal Cancer Centre, to announce results of Osta’s lead anti-cancer drug on Monday, October 15, 2007.
